Seniors with cancer respond just as well as younger patients to immune checkpoint inhibitors -- drugs that take the brakes ...

Researchers have developed an innovative nano-immune agonist that significantly improves immunotherapy outcomes for melanoma—a highly aggressive and hard-to-treat form of skin cancer.

The study, published in the Journal of Clinical Investigation, reveals that pyrvinium pamoate—a drug approved in the 1950s to ...

The study reexamined immunotherapy clinical trial data on bladder and skin cancer and found that "cold" tumors, ones that ...

Researchers Shed Light on How to Predict Which Skin Cancer Patients Are Most Likely to Respond to Immunotherapy Jan. 8, 2025 — An international team of UK and US scientists discovered that the ...

A new systematic review reveals promising results for oncolytic viral therapy in treating nonmelanoma skin cancers and ...

Researchers have found that tapping into the body's own immune system and activating a type of immune cell known as B cells, could be the key to boosting the effectiveness of tumor-infiltrating ...

Patients discontinuing adjuvant immunotherapy early due to toxicity ... The investigators queried a multicenter skin cancer database to identify 620 patients with American Joint Committee on ...

Patients with advanced skin cancer will be able to test a new vaccine as part of a drive to speed up the development of new ...

New York University researchers say a simple, gene-based blood test has shown to be highly accurate in predicting whether ...

Patients with advanced skin cancer will be able to test a new vaccine ... cancer cells and therefore better respond to existing immunotherapy treatment. By working to help the body recognise, ...